UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: (Date of earliest event reported:) July 16, 2015

 

UNITED HEALTH PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

814-00717

 

84-1517723

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

10624 S. Eastern Ave., Ste. A209

Henderson, NV 89052

(Address of principal executive offices, zip code)

 

(877) 358-3444

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))

 

 

  

Item 8.01. Other Events.

 

UNITED HEALTH PRODUCTS INC. ENGAGES MAXIM GROUP LLC, FOR CAPITAL MARKETS ADVISORY SERVICES

 

Henderson, NV - July 16, 2015 - United Health Products, Inc. (OTCQB: UEEC) announced today the engagement of Maxim Group LLC, a leading full-service investment bank, securities and wealth management firm. Maxim has been retained by the Company as financial advisor. Maxim Group LLC, based in New York, provides investment banking services, wealth management, prime brokerage services and merchant capital services as well as additional capital markets services.

 

 
2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

UNITED HEALTH PRODUCTS, INC.

 

 

 

Dated: July 16, 2015

By:

/s/ Douglas Beplate

 

 

 

Douglas Beplate

 

 

 

Chief Executive Officer

 

 

 

3